How can we help?
- Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
- Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor
- Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
- “The Therapeutic Potential of Cannabinoids for Movement
Disorders | Nervous System”